Trupanion, Inc. (NASDAQ:TRUP – Get Free Report) insider Brenna Mcgibney sold 5,000 shares of the stock in a transaction that occurred on Friday, March 7th. The shares were sold at an average price of $32.99, for a total transaction of $164,950.00. Following the sale, the insider now directly owns 3,738 shares in the company, valued at $123,316.62. This trade represents a 57.22 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink.
Trupanion Stock Up 2.3 %
Shares of TRUP stock traded up $0.74 on Tuesday, hitting $33.20. 586,401 shares of the stock were exchanged, compared to its average volume of 641,189. The firm has a market capitalization of $1.41 billion, a P/E ratio of -144.35, a price-to-earnings-growth ratio of 6.02 and a beta of 1.70. Trupanion, Inc. has a fifty-two week low of $19.69 and a fifty-two week high of $57.90. The business has a 50-day moving average of $43.80 and a 200 day moving average of $47.42. The company has a current ratio of 1.71, a quick ratio of 1.66 and a debt-to-equity ratio of 0.39.
Trupanion (NASDAQ:TRUP – Get Free Report) last released its earnings results on Wednesday, February 19th. The financial services provider reported $0.04 earnings per share for the quarter, missing analysts’ consensus estimates of $0.06 by ($0.02). The business had revenue of $337.31 million during the quarter, compared to the consensus estimate of $335.41 million. Trupanion had a negative net margin of 0.75% and a negative return on equity of 3.08%. Equities analysts anticipate that Trupanion, Inc. will post 0.13 EPS for the current year.
Institutional Inflows and Outflows
Wall Street Analyst Weigh In
TRUP has been the topic of several recent research reports. Stifel Nicolaus decreased their price target on Trupanion from $44.00 to $41.00 and set a “hold” rating on the stock in a report on Thursday, February 20th. Piper Sandler decreased their price objective on shares of Trupanion from $57.00 to $52.00 and set an “overweight” rating for the company in a report on Thursday, February 20th. Two equities research analysts have rated the stock with a hold rating, four have issued a buy rating and one has issued a strong buy rating to the company. Based on data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average target price of $46.60.
Trupanion Company Profile
Trupanion, Inc, together with its subsidiaries, provides medical insurance for cats and dogs on a monthly subscription basis in the United States, Canada, Continental Europe, and Australia. The company operates in two segments, Subscription Business and Other Business. It serves pet owners and veterinarians.
Featured Stories
- Five stocks we like better than Trupanion
- How to Use the MarketBeat Excel Dividend Calculator
- NVIDIA Stock Remains Stunningly Undervalued—Here’s Why
- Upcoming IPO Stock Lockup Period, Explained
- Oracle Stock: 5 Reasons This AI Powerhouse Is a Long-Term Buy
- High Flyers: 3 Natural Gas Stocks for March 2022
- U.S. Stocks Sink, Foreign Markets Soar: 3 ETFs to Ride the Wave
Receive News & Ratings for Trupanion Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Trupanion and related companies with MarketBeat.com's FREE daily email newsletter.